Fcpm Iii Services B.v.

Latest statistics and disclosures from Fcpm Iii Services B.v.'s latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NAMS, DYN, ENGN, RAPT, MPLT, and represent 83.28% of Fcpm Iii Services B.v.'s stock portfolio.
  • Added to shares of these 5 stocks: MPLT (+$57M), RAPT (+$50M), VOR (+$42M), CBIO (+$20M), BCYC.
  • Started 2 new stock positions in CBIO, MPLT.
  • Reduced shares in these 3 stocks: Astria Therapeutics (-$30M), REPL (-$13M), NAMS.
  • Sold out of its position in Astria Therapeutics.
  • Fcpm Iii Services B.v. was a net buyer of stock by $126M.
  • Fcpm Iii Services B.v. has $763M in assets under management (AUM), dropping by 52.46%.
  • Central Index Key (CIK): 0002013410

Tip: Access up to 7 years of quarterly data

Positions held by Fcpm Iii Services B.v. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Fcpm Iii Services B.v.

Fcpm Iii Services B.v. holds 10 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Newamsterdam Pharma Company Ordinary Shares (NAMS) 42.3 $323M 9.2M 35.08
 View chart
Dyne Therapeutics (DYN) 14.0 $107M 5.5M 19.56
 View chart
Engene Holdings (ENGN) 11.4 $87M 9.6M 9.03
 View chart
Rapt Therapeutics Com New (RAPT) 8.1 $62M +432% 1.8M 33.87
 View chart
Maplight Therapeutics (MPLT) 7.4 $57M NEW 3.2M 17.57
 View chart
Vor Biopharma Com New (VOR) 6.2 $47M +852% 3.6M 13.08
 View chart
Replimune Group (REPL) 3.6 $27M -32% 2.8M 9.72
 View chart
Bicycle Therapeutics Sponsored Ads (BCYC) 3.2 $25M 3.5M 7.08
 View chart
Crescent Biopharma (CBIO) 2.6 $20M NEW 1.7M 11.86
 View chart
Engene Holdings W Exp 10/31/2028 (ENGNW) 1.1 $8.5M 2.9M 2.96
 View chart

Past Filings by Fcpm Iii Services B.v.

SEC 13F filings are viewable for Fcpm Iii Services B.v. going back to 2023